Cargando…

How do patients interpret and respond to a single-item global indicator of cancer treatment tolerability?

BACKGROUND: There is increasing interest in patient-reported measures of cancer treatment tolerability. A global measure of bother, the FACT GP5 item (“I am bothered by side effects of treatment”) is potentially useful for regulatory, research, and clinical use. To understand this item’s appropriate...

Descripción completa

Detalles Bibliográficos
Autores principales:	Peipert, John Devin, Shaunfield, Sara, Kaiser, Karen, Moreno, Patricia I., Fox, Rina S., Kircher, Sheetal, Mohindra, Nisha, Ip, Edward, Zhao, Fengmin, Wagner, Lynne, Cella, David
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2022
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10356672/ https://www.ncbi.nlm.nih.gov/pubmed/36525100 http://dx.doi.org/10.1007/s00520-022-07484-7

Ejemplares similares

Correction to: How do patients interpret and respond to a single‑item global indicator of cancer treatment tolerability?
por: Peipert, John Devin, et al.
Publicado: (2023)

Neuropathy experienced by colorectal cancer patients receiving oxaliplatin: A qualitative study to validate the Functional Assessment of Cancer Therapy/Gynecologic Oncology Group-Neurotoxicity scale
por: Kaiser, Karen, et al.
Publicado: (2020)

Validity of a single-item indicator of treatment side effect bother in a diverse sample of cancer patients
por: Griffiths, Pip, et al.
Publicado: (2022)

General population reference values for the Functional Assessment of Cancer Therapy‐Lung and PROMIS‐29
por: Mohindra, Nisha A., et al.
Publicado: (2023)

Assessing Preferences for Rare Disease Treatment: Qualitative Development of the Paroxysmal Nocturnal Hemoglobinuria Patient Preference Questionnaire (PNH-PPQ(©))
por: Kaiser, Karen, et al.
Publicado: (2020)

Between-group minimally important change versus individual treatment responders
por: Hays, Ron D., et al.
Publicado: (2021)

Further content validation of the 18-item NCCN/FACT Ovarian Symptom Index and its Disease Related Symptom-Physical (DRS-P) subscale for use in advanced ovarian cancer clinical trials
por: Shaunfield, Sara, et al.
Publicado: (2019)

Reconsidering tolerability of cancer treatments: opportunities to focus on the patient
por: Peipert, John Devin, et al.
Publicado: (2022)

Correction to: Reconsidering tolerability of cancer treatments: opportunities to focus on the patient
por: Peipert, John Devin, et al.
Publicado: (2022)

Examining allostatic load, neighborhood socioeconomic status, symptom burden and mortality in multiple myeloma patients
por: Obeng-Gyasi, Samilia, et al.
Publicado: (2022)

Patient‐reported tolerability of veliparib combined with cisplatin and etoposide for treatment of extensive stage small cell lung cancer: Neurotoxicity and adherence data from the ECOG ACRIN cancer research group E2511 phase II randomized trial
por: Steffen McLouth, Laurie E., et al.
Publicado: (2020)

Identifying meaningful change on PROMIS short forms in cancer patients: a comparison of item response theory and classic test theory frameworks
por: Lee, Minji K., et al.
Publicado: (2022)

Adverse COVID-19 experiences and health-related quality of life in cancer survivors: indirect effects of COVID-19-related depression and financial burden
por: Perry, Laura M., et al.
Publicado: (2023)

Patient-Reported Outcome Dashboards Within the Electronic Health Record to Support Shared Decision-making: Protocol for Co-design and Clinical Evaluation With Patients With Advanced Cancer and Chronic Kidney Disease
por: Perry, Laura M, et al.
Publicado: (2022)

Optimizing brief, focused assessment of priority symptoms and concerns in recurrent and/or metastatic squamous cell carcinoma of the head and neck: Content validation of the Functional Assessment of Cancer Therapy/National Comprehensive Cancer Network Head and Neck Symptom Index‐10 (FHNSI‐10)
por: Shaunfield, Sara, et al.
Publicado: (2021)

Establishing the interpretability and utility of the 4-item BriefPCS
por: You, Dokyoung S., et al.
Publicado: (2023)

Parental self-efficacy managing a child’s medications and treatments: adaptation of a PROMIS measure
por: Foster, Carolyn C., et al.
Publicado: (2023)

Impact of insurance and neighborhood socioeconomic status on clinical outcomes in therapeutic clinical trials for breast cancer
por: Obeng‐Gyasi, Samilia, et al.
Publicado: (2020)

Development of a Functional Assessment of Chronic Illness Therapy item library and primary symptom list for the assessment of patient-reported adverse events associated with immune checkpoint modulators
por: Webster, Kimberly A., et al.
Publicado: (2020)

Qualitative development of the PROMIS Profile v1.0-Familial Chylomicronemia Syndrome (FCS) 28
por: Kaiser, Karen, et al.
Publicado: (2022)

Glucose Tolerance Tests and Their Interpretation
por: Bose, J. P.
Publicado: (1923)

Development of the NIH Patient-Reported Outcomes Measurement Information System (PROMIS) Medication Adherence Scale (PMAS)
por: Peipert, John Devin, et al.
Publicado: (2020)

Importance of Patient-Reported Outcome Measures on Clinical Practice in Patients With Kidney Disease
por: Frazier, Rebecca, et al.
Publicado: (2021)

Minimal important change (MIC): a conceptual clarification and systematic review of MIC estimates of PROMIS measures
por: Terwee, Caroline B., et al.
Publicado: (2021)

Two-item PROMIS® global physical and mental health scales
por: Hays, Ron D., et al.
Publicado: (2017)

Using IT to Improve Outcomes for Children Living With Cancer (SyMon-SAYS): Protocol for a Single-Institution Waitlist Randomized Controlled Trial
por: Lai, Jin-Shei, et al.
Publicado: (2023)

Problems with analyses and interpretation of data in “use of the KDQOL-36™ for assessment of health-related quality of life among dialysis patients in the United States”
por: Hays, Ron D., et al.
Publicado: (2019)

Methodology for the development and calibration of the SCI-QOL item banks
por: Tulsky, David S., et al.
Publicado: (2015)

Potential application of item-response theory to interpretation of medical codes in electronic patient records
por: Dregan, Alex, et al.
Publicado: (2011)

ANCHOR surgeon views of patient selection and expectations for periacetabular osteotomy
por: Edelstein, Adam I, et al.
Publicado: (2019)

Allocation of Study Time in Chinese Junior School Students: Habitual Responding, Item Difficulty, and Time Constraints
por: Wang, Fuyun, et al.
Publicado: (2016)

Bayesian Item Response Modeling: Theory and Applications
por: Fox, Jean-Paul
Publicado: (2010)

Italian Validation of the 12-Item Multiple Sclerosis Walking Scale
por: Solaro, C., et al.
Publicado: (2015)

Interpreting Bisphenol A Absorption in the Canine Oral Cavity: Gayrard et al. Respond
por: Gayrard, Véronique, et al.
Publicado: (2013)

The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation
por: Webster, Kimberly, et al.
Publicado: (2003)

Development and validation of the functional assessment of cancer therapy–antiangiogenesis subscale
por: Kaiser, Karen, et al.
Publicado: (2015)

Predicting EuroQol (EQ-5D) scores from the patient-reported outcomes measurement information system (PROMIS) global items and domain item banks in a United States sample
por: Revicki, Dennis A., et al.
Publicado: (2009)

Item-Score Reliability in Empirical-Data Sets and Its Relationship With Other Item Indices
por: Zijlmans, Eva A. O., et al.
Publicado: (2017)

Psychometric validation of the Persian nine-item Internet Gaming Disorder Scale – Short Form: Does gender and hours spent online gaming affect the interpretations of item descriptions?
por: Wu, Tzu-Yi, et al.
Publicado: (2017)

Protocol for a type 2 hybrid effectiveness-implementation study expanding, implementing and evaluating electronic health record-integrated patient-reported symptom monitoring in a multisite cancer centre
por: Garcia, Sofia F, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hmosdftug4ad0hko6pp4o9fkoq